Ranbaxy Laboratories Ltd.
Ranbaxy Laboratories Ltd., a prominent player in the pharmaceutical industry, is headquartered in India. Founded in 1961, the company has established itself as a leader in the development and manufacturing of generic and branded medications, with a strong presence in various global markets, including North America, Europe, and Asia. Specialising in a diverse range of therapeutic areas, Ranbaxy offers a unique portfolio of products, including antibiotics, cardiovascular medications, and anti-diabetics. The company is recognised for its commitment to quality and innovation, having achieved significant milestones such as the introduction of several first-to-file generic drugs. With a robust market position, Ranbaxy has garnered numerous accolades for its contributions to healthcare, making it a trusted name in the pharmaceutical sector. Its dedication to research and development continues to drive its success in delivering affordable healthcare solutions worldwide.
DitchCarbon Score
How does Ranbaxy Laboratories Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ranbaxy Laboratories Ltd.'s score of 18 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Ranbaxy Laboratories Ltd.'s reported carbon emissions
Ranbaxy Laboratories Ltd., headquartered in India, currently does not have available data on its carbon emissions, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions data to analyse. In terms of climate commitments, there are no documented reduction targets or initiatives outlined in the available information. This lack of data suggests that Ranbaxy may not have publicly committed to specific climate action goals or reduction strategies at this time. As the pharmaceutical industry increasingly focuses on sustainability and reducing carbon footprints, it will be essential for Ranbaxy to establish clear climate commitments and measurable targets to align with global efforts in combating climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ranbaxy Laboratories Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
